PREVENTION OF COMPLICATIONS AFTER TRANSRECTAL PROSTATE BIOPSY
- 作者: Gevorkyan A.1, Avakyan A.1
-
隶属关系:
- Polyclinic One Hundred and Ninety-Five, West Administrative District, Moscow
- 期: 卷 24, 编号 6 (2013)
- 页面: 69-71
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115718
- ID: 115718
如何引用文章
详细
The rate of infectious complications after transrectal prostate cancer in the Urology Unit of Polyclinic One Hundred and Ninety-Five (West Administrative District, Moscow) in 2009-2011 is analyzed by the results of biopsy specimen inoculation for pathogenic flora and those of postbiopsy antibiotic sensitivity determination.
全文:
作者简介
A. Gevorkyan
Polyclinic One Hundred and Ninety-Five, West Administrative District, Moscow
Email: armmed1@mail.ru
Candidate of Medical Sciences
A. Avakyan
Polyclinic One Hundred and Ninety-Five, West Administrative District, Moscow
参考
- Boyle P., Ferlay J. Cancer incidence and mortality in Europe 2004 // Ann. Oncol. - 2005; 16 (3): 481-8.
- Jemal A., Siegel R., Ward E. et al. Cancer statistics, 2008 // CA Cancer J. Clin. - 2008; 58 (2): 71-96.
- Чиссов В.И., Старинский В.В. Ход реализации мероприятий по совершенствованию онкологической помощи населению России. МНИОИ им. П.А. Герцена // Рос. онкол. журн. - 2011; 4.
- Велиев Е.И., Богданов А.Б. Формирование показаний к первичной и повторной трансректальной мультифокальной биопсии предстательной железы и вероятные осложнения // Урология сегодня. - 2010; 1.
- Webb N., Woo H. Antibiotic prophylaxis for prostate biopsy // BJU Int. -2002; 89: 824-8.
- Nobrega de Jesus C., Correa L., Padovani C. Complications and risk factors in transrectal ultrasound-guided prostate biopsies // San Paulo Med. J. - 2006; 124 (4): 198-202.
- Miura T., Tanaka K., Shigemura K. et al. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: Report of four cases and review of the literature // Int. J.Urol. - 2008; 15: 457-9.
- Scotton P., Vaglia A., Rizzi M. et al. Which antibiotic prophylaxis to use for urologic procedures in patients at risk for infective endocarditis: a report on two cases // Infez. Med. - 2006; 14 (4): 246-7.
- Crundwell M., Cooke P., Wallace D. Patients’ tolerance of transrectal ultrasound-guided prostatic biopsy: an audit of 104 cases // BJU Int. - 1999; 83: 792-5.
- Puig J., Darnell A., Bermudez P. et al. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? // Eur. Radiol. - 2006; 16: 939-43.
- Aron M., Rajeev T.P, Gupta N.P. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study // BJU Int. - 2000; 85: 682-5.
- Kapoor D., Klimberg I., Malek G. et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy // Urology. - 1998; 52: 552-8.
- Зайцев А.В., Пушкарь Д.Ю., Раснер П.И. и др. Антибактериальная профилактика при трансректальной биопсии предстательной железы // РМЖ. -2009; 17 (14): 910-3.
- Shandera K., Thibault G., Deshon G. Jr. Variability in patient preparation for prostate biopsy among American urologists // Urology. - 1998; 52: 644-6.
- Burden H., Ranasinghe W., Persad R. Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practicing evidence-based medicine? BJU Int. - 2008; 101: 1202-4.
- Schaeffer A., Montorsi F., Scattoni V. et al. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate // BJU Int. - 2007; 100: 51-7.
- Briffaux R., Coloby P., Bruyere F. et al. One preoperative dose randomized against 3-day antibiotic prophylaxis for transrectal ultrasonography-guided prostate biopsy // BJU Int. - 2008; 103: 1069-73.
- Тal R., Livne P., Lask D. et al. Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy // J. Urol. -2003; 169: 1762-5.
- Drusano G., Preston S., Van Guilder M. et al. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin // Antimicrob. Agents Chemother. - 2000; 44 (8): 2046-51.
- Croom K., Goa K.L. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States // Drugs. - 2003; 63 (24): 2768-802.
- Naber K. Levofloxacin in the treatment of urinary tract infection and prostatitis // J. Chemother. - 2004; 16 (2): 18-21.
- Griffith B., Morey A., Ali-Khan M. et al. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk // J. Urol. - 2002; 168 (3): 1021-3.
- Shigehara K., Miyagi T., Nakashima T. et al. Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis // J. Infect. Chemother. - 2008; 14 (1): 40-3. Epub. Feb. 24 2008.